{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:50:59Z","timestamp":1722880259323},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The National Health Service Corps (NHSC) Loan Repayment Program (LRP) expansion in fiscal year (FY) 2019 intended to improve access to medication for opioid use disorder (MOUD) by adding more clinicians who could prescribe buprenorphine. However, some clinicians still face barriers to prescribing, which may vary between rural and nonrural areas.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the growth in buprenorphine prescribing by NHSC clinicians for Medicaid beneficiaries during the NHSC LRP expansion and describe the challenges to prescribing that persist in rural and nonrural areas.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study analyzed preexpansion and postexpansion Medicaid claims data to evaluate the percentage of prescriptions of buprenorphine filled during FY 2017 through 2021. This study also analyzed challenges and barriers to prescribing MOUD between rural and urban areas, using results from annual surveys conducted with NHSC clinicians and sites from FY 2019 through FY 2021.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Prescribing of buprenorphine by NHSC clinicians.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcomes were the percentage and number of Medicaid beneficiaries with opioid use disorder (OUD) who filled a prescription for buprenorphine before and after the LRP expansion and the challenges NHSC clinicians and sites faced in providing substance use disorder and OUD services. Survey results were analyzed using descriptive statistics.<\/jats:p><\/jats:sec>Results<\/jats:title>During FYs 2017 through 2021, 7828 NHSC clinicians prescribed buprenorphine (standard LRP: mean [SD] age, 38.1 [8.4] years and 4807 females [78.9%]; expansion LRPs: mean [SD] age, 39.4 [8.1] years and 1307 females [75.0%]). A total of 3297 NHSC clinicians and 4732 NHSC sites responded to at least 1 survey question to the 3 surveys. The overall percentage of Medicaid beneficiaries with OUD who filled a prescription for buprenorphine during the first 2.5 years post expansion increased significantly from 18.9% before to 43.7% after expansion (an increase of 123\u202f422 beneficiaries; P<\/jats:italic>\u2009&amp;lt;\u2009.001). The percentage more than doubled among beneficiaries living in areas with a high Social Vulnerability Index score (from 17.0% to 36.7%; an increase of 31\u202f964) and among beneficiaries living in rural areas (from 20.8% to 55.7%; an increase of 45\u202f523). However, 773 of 2140 clinicians (36.1%; 95% CI, 33.6%-38.6%) reported a lack of mental health services to complement medication for OUD treatment, and 290 of 1032 clinicians (28.1%; 95% CI, 24.7%-31.7%) reported that they did not prescribe buprenorphine due to a lack of supervision, mentorship, or peer consultation.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that although the X-waiver requirement has been removed and Substance Abuse and Mental Health Services Administration guidelines encourage all eligible clinicians to screen and offer patients with OUD buprenorphine, as permissible by state law, more trained health care workers and improved care coordination for counseling and referral services are needed to support comprehensive OUD treatment.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.11742","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:31:37Z","timestamp":1715959897000},"page":"e2411742","source":"Crossref","is-referenced-by-count":0,"title":["Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians"],"prefix":"10.1001","volume":"7","author":[{"given":"Kathleen","family":"Rowan","sequence":"first","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savyasachi V.","family":"Shah","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Binns","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Murphy","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Satorius","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Ghobadi","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Krauss","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Robbins","sequence":"additional","affiliation":[{"name":"Health Resources and Services Administration Bureau of Health Workforce, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Schoebel","sequence":"additional","affiliation":[{"name":"Health Resources and Services Administration Bureau of Health Workforce, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Knudson","sequence":"additional","affiliation":[{"name":"NORC at the University of Chicago, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayden","family":"Kepley","sequence":"additional","affiliation":[{"name":"Health Resources and Services Administration Bureau of Health Workforce, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Bureau of Health Workforce Substance Use Disorder Evaluation Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"none","given":"Srabani","family":"Das","sequence":"additional","affiliation":[{"name":"for the Bureau of Health Workforce Substance Use Disorder Evaluation Team"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"none","given":"Kiplin","family":"Kaldahl","sequence":"additional","affiliation":[{"name":"for the Bureau of Health Workforce Substance Use Disorder Evaluation Team"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"none","given":"Ryan","family":"Murphy","sequence":"additional","affiliation":[{"name":"for the Bureau of Health Workforce Substance Use Disorder Evaluation Team"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"issue":"2","key":"zoi240418r3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jac5.v5.2","article-title":"Pharmacists and opioid use disorder care during COVID-19: call for action.","volume":"5","author":"Mohammad","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"key":"zoi240418r4","doi-asserted-by":"publisher","DOI":"10.31478\/namperspectives","article-title":"Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system.","volume":"2020","author":"Madras","year":"2020","journal-title":"NAM Perspect"},{"issue":"5","key":"zoi240418r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12419","article-title":"Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the Drug Addiction Treatment Act of 2000 waiver.","volume":"5","author":"Lanham","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi240418r6","doi-asserted-by":"publisher","DOI":"10.1080\/10872981.2020.1847755","article-title":"Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.","volume":"26","author":"Lien","year":"2021","journal-title":"Med Educ Online"},{"issue":"9","key":"zoi240418r9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s11606-022-07975-7","article-title":"Increasing access to buprenorphine for opioid use disorder in primary care: an assessment of provider incentives.","volume":"38","author":"Kelley","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"7","key":"zoi240418r10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/10826084.2021.1906280","article-title":"Linking MATTERS: barriers and facilitators to implementing emergency department-initiated buprenorphine-naloxone in patients with opioid use disorder and linkage to long-term care.","volume":"56","author":"Sokol","year":"2021","journal-title":"Subst Use Misuse"},{"issue":"1","key":"zoi240418r11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jama.2023.7138","article-title":"A physician crisis in the rural US may be about to get worse.","volume":"330","author":"Grover","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"zoi240418r13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1176\/appi.ps.20220244","article-title":"Role of the National Health Service Corps in delivering substance use disorder treatment in underserved communities.","volume":"74","author":"Rowan","year":"2023","journal-title":"Psychiatr Serv"},{"key":"zoi240418r14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.20230258","article-title":"Impact of U.S. federal loan repayment programs on the behavioral health workforce: scoping review.","author":"Last","year":"2024","journal-title":"Psychiatr Serv"},{"issue":"1","key":"zoi240418r22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"5","key":"zoi240418r23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1176\/appi.ps.202000565","article-title":"How physician workforce shortages are hampering the response to the opioid crisis.","volume":"73","author":"McNeely","year":"2022","journal-title":"Psychiatr Serv"},{"issue":"5","key":"zoi240418r25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/09540261.2018.1514369","article-title":"Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations.","volume":"30","author":"Speed","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"zoi240418r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108923","article-title":"National trends in buprenorphine prescribing before and during the COVID-19 pandemic.","volume":"144","author":"Ali","year":"2023","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi240418r27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5811\/WESTJEM.58895","article-title":"Utilization of telehealth solutions for patients with opioid use disorder using buprenorphine: a scoping review.","volume":"28","author":"Guillen","year":"2022","journal-title":"Telemed J E Health"},{"volume-title":"The Opioid Epidemic and Medicaid\u2019s Role in Facilitating Access to Treatment","year":"2019","author":"Orgera","key":"zoi240418r16"},{"key":"zoi240418r1","doi-asserted-by":"crossref","unstructured":"Spencer? MR. Mini\u00f1o? AM, Warner? M. Drug overdose deaths in the United States, 2001\u20132021. National Center for Health Statistics Data Brief No. 457. Centers for Disease Control and Prevention. 2022. Accessed July 30, 2023. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db457.htm","DOI":"10.15620\/cdc:122556"},{"key":"zoi240418r2","unstructured":"Ahmad? F, Cisewski? J, Rossen? L, Sutton? P. Provisional drug overdose death counts. Centers for Disease Control and Prevention. October 2, 2023. Accessed October 12, 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi240418r7","unstructured":"Waiver Elimination (MAT Act). Substance Abuse and Mental Health Services Administration. January 10, 2023. Accessed October 18, 2023. https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/waiver-elimination-mat-act"},{"key":"zoi240418r8","unstructured":"DEA, SAMHSA extend COVID-19 telemedicine flexibilities for prescribing controlled medications for six months while considering comments from the public. Substance Abuse and Mental Health Services Administration. May 9, 2023. Accessed October 18, 2023. https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/20230509\/dea-extend-covid19-telemedicine-flexibilities-prescribing-controlled-medications"},{"key":"zoi240418r12","unstructured":"What is a medically underserved area\/population (MUA\/P)? Health Resources and Services Administration. Accessed October 18, 2023. https:\/\/bhw.hrsa.gov\/workforce-shortage-areas\/shortage-designation#mups"},{"key":"zoi240418r15","unstructured":"Underrepresented minority (URM). Health Resources and Services Administration. Accessed April 9, 2024. https:\/\/bhw.hrsa.gov\/glossary#u"},{"key":"zoi240418r17","unstructured":"Medicaid Section 1115 Substance Use Disorder Demonstrations: Technical Specifications for Monitoring Metrics. Version 4.0. Medicaid.gov. Accessed April 9, 2024. https:\/\/www.medicaid.gov\/sites\/default\/files\/2023-08\/ak-sud-bhp-qrtly-monitor-rpt-parta-oct-dec-2021.xlsx"},{"key":"zoi240418r18","unstructured":"DQAtlas. Centers for Medicare & Medicaid Services; 2021. Accessed March 20, 2023. https:\/\/www.medicaid.gov\/dq-atlas\/landing\/topics\/info"},{"key":"zoi240418r19","unstructured":"Federal Office of Rural Health Policy (FORHP) data files. Health Resources and Services Administration. Accessed April 24, 2023. https:\/\/www.hrsa.gov\/rural-health\/about-us\/what-is-rural\/data-files"},{"key":"zoi240418r20","unstructured":"Defining rural population. Health Resources and Services Administration. Accessed April 9, 2024. https:\/\/www.hrsa.gov\/rural-health\/about-us\/what-is-rural"},{"key":"zoi240418r21","unstructured":"CDC\/ATSDR SVI data and documentation download. Agency for Toxic Substances and Disease Registry. 2020. Accessed April 30, 2023. https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/data_documentation_download.html"},{"key":"zoi240418r24","unstructured":"Workforce projections. Health Resources and Services Administration. Accessed April 10, 2024. https:\/\/data.hrsa.gov\/topics\/health-workforce\/workforce-projections"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2818952\/rowan_2024_oi_240418_1715361693.7147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:31:41Z","timestamp":1715959901000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2818952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.11742","relation":{},"ISSN":["2574-3805"],"issn-type":[{"type":"electronic","value":"2574-3805"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}